Kidney TransplantationKidneyGraft RejectionGraft SurvivalKidney DiseasesImmunosuppressive AgentsKidney Failure, ChronicTissue DonorsLiver DiseasesLiving DonorsTacrolimusLiver TransplantationKidney TubulesLiverTransplantation, HomologousMycophenolic AcidTransplantationCyclosporineTissue and Organ ProcurementCadaverTime FactorsWaiting ListsDelayed Graft FunctionTransplantsLiver NeoplasmsKidney Function TestsAcute Kidney InjuryBK VirusTreatment OutcomeKidney CortexRetrospective StudiesLiver CirrhosisImmunosuppressionPancreas TransplantationGlomerular Filtration RatePolyomavirus InfectionsCreatininePostoperative ComplicationsHistocompatibility TestingKidney NeoplasmsKidney GlomerulusRisk FactorsMicrosomes, LiverLiver RegenerationDirected Tissue DonationPolycystic Kidney DiseasesHeart TransplantationFatty LiverIsoantibodiesFollow-Up StudiesAntilymphocyte SerumRenal DialysisKidney Tubules, ProximalKidney MedullaBiopsyDonor SelectionLung TransplantationLiver Function TestsCytomegalovirus InfectionsHLA AntigensNephrectomyProspective StudiesRenal InsufficiencyPrimary Graft DysfunctionKidney CalculiIranBiological MarkersSurvival RateMitochondria, LiverComplement C4bCalcineurinSirolimusImmunocompromised HostKidney Tubular Necrosis, AcuteDrug-Induced Liver InjuryIncidencePolycystic Kidney, Autosomal DominantTransplantation ImmunologyKidney Tubules, CollectingCohort StudiesProteinuriaProportional Hazards ModelsHistocompatibilityBrain DeathDrug Therapy, CombinationGingival HypertrophyAzathioprineUreterRisk AssessmentUreteral DiseasesPrognosisSurvival AnalysisRNA, MessengerKaplan-Meier EstimateLiver CirculationBone Marrow TransplantationChronic DiseaseDrug MonitoringTissue DistributionBlood Group Incompatibility